Impact of lymphopenia on COVID-19 infection severity

المؤلفون المشاركون

Tariq, Ali Ayyad
Hamid, Naqa Majid
Abd al-Shahid, Tabarak Salim

المصدر

Medical Journal of Babylon

العدد

المجلد 19، العدد 1 (31 مارس/آذار 2022)، ص ص. 99-101، 3ص.

الناشر

جامعة بابل كلية الطب

تاريخ النشر

2022-03-31

دولة النشر

العراق

عدد الصفحات

3

التخصصات الرئيسية

الطب البشري

الموضوعات

الملخص EN

Coronavirus disease-2019 (COVID-19) is an infectious disease caused by a new Coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-COV-2).

world health organization (WHO) first learned of this new virus on December 31, 2019, following a report of a cluster of cases of “viral pneumonia” in Wuhan, people's republic of china.

WHO declared the outbreak a public health emergency of international concern on January 30, 2020, and a pandemic on march 11, 2020.

globally according to WHO data, as of September 9, 2021 there were 4, 592, 934 deaths occurred due to this disease.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Tariq, Ali Ayyad& Hamid, Naqa Majid& Abd al-Shahid, Tabarak Salim. 2022. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon،Vol. 19, no. 1, pp.99-101.
https://search.emarefa.net/detail/BIM-1339246

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Tariq, Ali Ayyad…[et al.]. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon Vol. 19, no. 1 (Jan. / Mar. 2022), pp.99-101.
https://search.emarefa.net/detail/BIM-1339246

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Tariq, Ali Ayyad& Hamid, Naqa Majid& Abd al-Shahid, Tabarak Salim. Impact of lymphopenia on COVID-19 infection severity. Medical Journal of Babylon. 2022. Vol. 19, no. 1, pp.99-101.
https://search.emarefa.net/detail/BIM-1339246

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references : p. 100-101

رقم السجل

BIM-1339246